Grifols SA – Strategy, SWOT and Corporate Finance Report
- Pages: 65
- Published: May 2019
- Report Code: MLPH7524FSA
Grifols SA – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360Ëš view of the company.
Grifols SA (Grifols) focuses on improving the health and well-being of people around the world. It conducts research, development, manufacturing and marketing of plasma-derived therapies, hospital pharmacy products and diagnostic technology for clinical use. The company specializes in the production of plasma-derived medicines and has plasma donation centers across the US. Grifols provides a wide range of transfusion medicine, hemostasis and immunoassay solutions for blood banks, clinical laboratories and transfusion centers. It produces plasma derived protein therapies for patients suffering with rare, genetic diseases and life-threatening infections. The company offers its products to hospitals, pharmacies and healthcare professionals. Grifols is headquartered in Sant Cugat del Valles, Barcelona, Spain.
Scope
Detailed information on Grifols SA required for business and competitor intelligence needs
A study of the major internal and external factors affecting Grifols SA in the form of a SWOT analysis
An in-depth view of the business model of Grifols SA including a breakdown and examination of key business segments
News about Grifols SA, such as business expansion, restructuring, and contract wins
Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to buy
Gain understanding of Grifols SA and the factors that influence its strategies.Track strategic initiatives of the company and latest corporate news and actions.
Assess Grifols SA as a prospective partner, vendor or supplier.
Support sales activities by understanding your customers' businesses better.
Stay up to date on Grifols SAs business structure, strategy and prospects.
Note: Some sections may be missing if data is unavailable for the company.
Companies mentioned
AB-Biotics SA
Omnicell Inc
HemaCare Corp
CSL Ltd
Oryzon Genomics SA
Abeona Therapeutics Inc
Table of Contents
List of Tables
List of Figures
Pricing
Discounts available for multiple report purchases.